Quanterix (QTRX) EBT Margin Growth (1y) (2018 - 2026)
Quanterix (QTRX) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | -287.00 |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | -464.00 |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 772.00 |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 233.00 |
| 10 | Quanterix | 178.52 Mn | 79.26 Mn | 15.57 Mn | 2,901.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,901.00 |
| Dec 31, 2025 | -1,883.00 |
| Sep 30, 2025 | -6,655.00 |
| Jun 30, 2025 | -10,178.00 |
| Mar 31, 2025 | -4,295.00 |
| Dec 31, 2024 | -561.00 |
| Sep 30, 2024 | -228.00 |
| Jun 30, 2024 | -389.00 |
| Mar 31, 2024 | -918.00 |
| Dec 31, 2023 | 4,239.00 |
| Sep 30, 2023 | 11,626.00 |
| Jun 30, 2023 | 9,665.00 |
| Mar 31, 2023 | 3,624.00 |
| Dec 31, 2022 | -1,059.00 |
| Sep 30, 2022 | -8,046.00 |
| Jun 30, 2022 | -6,718.00 |
| Mar 31, 2022 | -2,402.00 |
| Dec 31, 2021 | -2,123.00 |
| Sep 30, 2021 | -6,311.00 |
| Jun 30, 2021 | 4,710.00 |